[go: up one dir, main page]

Straight et al., 1985 - Google Patents

Structural and functional characterization of the inhibition of urokinase by. alpha. 2-macroglobulin

Straight et al., 1985

Document ID
8526213461828400720
Author
Straight D
Hassett M
McKee P
Publication year
Publication venue
Biochemistry

External Links

Snippet

We have investigated the interaction of a2-macroglobulin (a2M) with theserine proteinase urokinase, an activator of plasminogen. Urokinase formed sodium dodecyl sulfate stable complexes with purified a2M and with a2M in plasma. These complexes could be …
Continue reading at pubs.acs.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase

Similar Documents

Publication Publication Date Title
Vassalli et al. Amiloride selectively inhibits the urokinase‐type plasminogen activator
Swenson et al. Snake venom fibrin (ogen) olytic enzymes
Bilezikian et al. Unique pattern of fibrinogen cleavage by human leukocyte proteases
Salonen et al. Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin.
Björk et al. The active site of antithrombin. Release of the same proteolytically cleaved form of the inhibitor from complexes with factor IXa, factor Xa, and thrombin.
Fenton et al. Human thrombins. Production, evaluation, and properties of alpha-thrombin.
Pannell et al. Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect
Morita et al. Preparation and properties of derivatives of bovine factor X and factor Xa from which the gamma-carboxyglutamic acid containing domain has been removed.
Aoki et al. Fibrinolytic states in a patient with congenital deficiency of α2-plasmin inhibitor
Yonekawa et al. Localization in the fibrinogen γ-chain of a new site that is involved in the acceleration of the tissue-type plasminogen activator-catalysed activation of plasminogen
Nielsen et al. Plasminogen activators catalyse conversion of inhibitor from fibrosarcoma cells to an inactive form with a lower apparent molecular mass
Weitz et al. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
Knudsen et al. Matrix plasminogen activator inhibitor. Modulation of the extracellular proteolytic environment.
Haley et al. The activation of bovine protein C by factor Xa
Marcum et al. Species specificity of streptokinase
Retzios et al. Purification, characterization, and fibrinogen cleavage sites of three fibrinolytic enzymes from the venom of Crotalus basiliscus basiliscus
Straight et al. Structural and functional characterization of the inhibition of urokinase by. alpha. 2-macroglobulin
Shih et al. Plasminogen and plasminogen activator assembly on the human endothelial cell
Loskutoff et al. Fibrinolytic system of cultured endothelial cells: regulation by plasminogen activator inhibitor
US6025330A (en) Inhibitors of fibrin cross-linking and/or transglutaminases
Braun et al. Preparation and characterization of proteolyzed forms of human α-thrombin
Swenson et al. α-Fibrinogenases
Plow et al. The plasma carboxypeptidases and the regulation of the plasminogen system
Pratt et al. Inflammatory cells degrade inter-α inhibitor to liberate urinary proteinase inhibitors
Souza et al. Inhibition of mutalysin II, a metalloproteinase from bushmaster snake venom by human α2-macroglobulin and rabbit immunoglobulin